Improved left ventricular mass index in children after renal transplantation

被引:30
作者
Becker-Cohen, Rachel [1 ,2 ]
Nir, Amiram [2 ,3 ]
Ben-Shalom, Efrat [1 ,2 ]
Rinat, Choni [1 ,2 ]
Feinstein, Sofia [1 ,2 ]
Farber, Benjamin [2 ,3 ]
Frishberg, Yaacov [1 ,2 ]
机构
[1] Shaare Zedek Med Ctr, Div Pediat Nephrol, IL-91031 Jerusalem, Israel
[2] Hadassah Hebrew Univ, Sch Med, Jerusalem, Israel
[3] Shaare Zedek Med Ctr, Div Pediat Cardiol, IL-91031 Jerusalem, Israel
关键词
left ventricular hypertrophy; hypertension; renal transplantation; pediatric;
D O I
10.1007/s00467-008-0855-5
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Left ventricular hypertrophy (LVH) is a risk factor for cardiovascular disease, and it is prevalent in children with end-stage renal disease (ESRD) and after renal transplantation (RTx) on cross-sectional studies. Our aim was to compare prospectively left ventricular mass index (LVMI) in children with ESRD, before and after RTx. Thirteen patients aged 1.5-15 years underwent echocardiogram prior to and at least 3 months after RTx, and again in the second year after transplantation. A control group consisted of children with ESRD who remained on dialysis. Systolic and diastolic blood pressure index decreased significantly over the study period only in the children who had undergone RTx. Mean LVMI in children with ESRD decreased from 45.4+/-12.6 g/m(2.7) to 34.9+/-10.4 g/m(2.7) after RTx (P=0.001), but it remained unchanged in patients who remained on dialysis. The prevalence of LVH decreased from 54% to 8% (P=0.03) after RTx. Systolic and diastolic blood pressure index were correlated with LVMI. Mean body mass index increased during the study period from 17.3+/-2.5 to 20+/-4.6 (P=0.05); however, no correlation was found with LVMI. LVH in children with ESRD is potentially reversible after RTx, especially with good control of hypertension.
引用
收藏
页码:1545 / 1550
页数:6
相关论文
共 22 条
[1]
Risk factors for cardiovascular disease in children and young adults after renal transplantation [J].
Becker-Cohen, Rachel ;
Nir, Amiram ;
Rinat, Choni ;
Feinstein, Sofia ;
Algur, Nurit ;
Farber, Benjamin ;
Frishberg, Yaacov .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06) :1284-1292
[2]
LEFT-VENTRICULAR MASS AND BODY SIZE IN NORMOTENSIVE CHILDREN AND ADULTS - ASSESSMENT OF ALLOMETRIC RELATIONS AND IMPACT OF OVERWEIGHT [J].
DESIMONE, G ;
DANIELS, SR ;
DEVEREUX, RB ;
MEYER, RA ;
ROMAN, MJ ;
DEDIVITIIS, O ;
ALDERMAN, MH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (05) :1251-1260
[3]
Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation [J].
El-Husseini, AA ;
Sheashaa, HA ;
Hassan, NA ;
El-Demerdash, FM ;
Sobh, MA ;
Ghoneim, MA .
PEDIATRIC TRANSPLANTATION, 2004, 8 (03) :249-254
[4]
Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHD [J].
Espino, G ;
Denney, J ;
Furlong, T ;
Fitzsimmons, W ;
Nash, RA .
BONE MARROW TRANSPLANTATION, 2001, 28 (12) :1097-1103
[5]
Cardiovascular effects of successful renal transplantation:: A 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile [J].
Ferreira, SRC ;
Moisés, VA ;
Tavares, A ;
Pacheco-Silva, A .
TRANSPLANTATION, 2002, 74 (11) :1580-1587
[6]
Regression of left ventricular hypertrophy by lisinopril after renal transplantation:: Role of ACE gene polymorphism [J].
Hernández, D ;
Lacalzada, J ;
Salido, E ;
Linares, J ;
Barragán, A ;
Lorenzo, V ;
Higueras, L ;
Martín, B ;
Rodríguez, A ;
Laynez, I ;
González-Posada, JM ;
Torres, A .
KIDNEY INTERNATIONAL, 2000, 58 (02) :889-897
[7]
Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy [J].
Ji, S.-M. ;
Li, L.-S. ;
Sha, G.-Z. ;
Chen, J.-S. ;
Liu, Z.-H. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (05) :1402-1405
[8]
Left ventricular abnormalities in children, adolescents and young adults with renal disease [J].
Johnstone, LM ;
Jones, CL ;
Grigg, LE ;
Wilkinson, JL ;
Walker, RG ;
Powell, HR .
KIDNEY INTERNATIONAL, 1996, 50 (03) :998-1006
[9]
MOLECULAR INSIGHTS INTO UREMIC CARDIOMYOPATHY: CARDIOTONIC STEROIDS AND NA/K ATPASE SIGNALING [J].
Kennedy, D. J. ;
Malhotra, D. ;
Shapiro, J. I. .
CELLULAR AND MOLECULAR BIOLOGY, 2006, 52 (08) :3-14
[10]
Predictors of cardiovascular events in patients with end-stage renal disease:: an analysis from the Fosinopril in Dialysis study [J].
Kessler, Michele ;
Zannad, Faiez ;
Lehert, Philippe ;
Gruenfeld, Jean Pierre ;
Thuilliez, Christian ;
Leizorovicz, Alain ;
Lechat, Philippe .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (12) :3573-3579